340B Accountability Act of 2023

Hozzl · 2023-12-15T16:07:02Z

Explore the details of Senate Bill 1133 340B Accountability Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/15/2023, 4:07 PM

Summary of Bill S 1133

Bill 118 s 1133, also known as the 340B Accountability Act of 2023, is a piece of legislation currently being considered by the US Congress. The bill aims to increase transparency and accountability in the 340B Drug Pricing Program, which requires drug manufacturers to provide discounts on outpatient drugs to certain healthcare facilities that serve low-income and vulnerable populations.

The 340B program has come under scrutiny in recent years for potential misuse and lack of oversight. The 340B Accountability Act of 2023 seeks to address these concerns by requiring participating healthcare facilities to report on how they are using the discounts they receive, including information on the number of patients served and the amount of savings realized.

Additionally, the bill would establish a process for auditing and enforcing compliance with program requirements, as well as penalties for non-compliance. It also includes provisions to improve the transparency of drug pricing and ensure that the discounts provided by manufacturers are passed on to patients in need. Overall, the 340B Accountability Act of 2023 aims to strengthen the integrity of the 340B program and ensure that it is effectively serving its intended purpose of providing affordable medications to underserved populations.

Congressional Summary of S 1133

340B Accountability Act of 2023

This bill requires participants in the 340B drug pricing program to allow the Health Resources & Services Administration (HRSA) to audit their records to determine how they use the net income from the discounted drug prices under the program. Participants also must retain records and reports as necessary for HRSA to perform the audits.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill S 1133

Bill S 1133 is currently in the status of Bill Introduced since March 30, 2023. Bill S 1133 was introduced during Congress 118 and was introduced to the Senate on March 30, 2023. Bill S 1133's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 30, 2023

Bipartisan Support of Bill S 1133

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 1133

Primary Policy Focus

Health

Alternate Title(s) of Bill S 1133

340B Accountability Act of 2023340B Accountability Act of 2023A bill to amend the Public Health Service Act to clarify rules relating to drug discounts for covered entities.

Start holding our government accountable!

Comments

Sponsors and Cosponsors of S 1133

Mike Braun

Indiana(Republican)

Latest Bills

340B Accountability Act of 2023

Summary of Bill S 1133

Congressional Summary of S 1133

Read the Full Bill

Current Status of Bill S 1133

Bipartisan Support of Bill S 1133

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill S 1133

Primary Policy Focus

Alternate Title(s) of Bill S 1133

Comments

Sponsors and Cosponsors of S 1133

Mike Braun

Latest Bills

Building Capacity for Care Act

NORRA of 2025

Women Veterans Cancer Care Coordination Act

Support UNFPA Funding Act

Access to Family Building Act

Establishing the Congressional Fitness Challenge, and for other purposes.

COST of Relocations Act

Ensuring Continuity in Veterans Health Act

Firearm Due Process Protection Act

No Paydays for Hostage-Takers Act

340B Transparency Act